However, as clinicians celebrate these advances, a Read More Why Early Combination Therapy Is Gaining Momentum in Young-Onset Type 2 Diabetes May 19, 2026 Articles, Blood Glucose Control, Devices, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Metformin Therapy Center, SGLT-2 Therapy Center, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,711 views Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults
Both drugs are delivered via subcutaneous (beneath the skin) injection using autoinjectors (patients can self-administer the injection at home)
This means the safety margin beyond the BUD may be narrower
XiaYJinJSunYKongXShenZYanRet al